Breaking Funeral Services for Senator Lindsey Graham Begin in Washington D.C. Arizona School for the Deaf and Blind Accused of Violating Federal Disability Law Philadelphia Eagles Sign Jalen Carter to Record-Breaking Extension Pakistan-Administered Kashmir Officials Accuse Group of Election Sabotage Amidst Clashes U.S. Delegation Walks Out of UN Security Council Meeting Amidst French Criticism

Tuesday July 28, 2026

Reporter

NanoViricides

4Articles Published

4Communities Covered

Published Articles

Press Release

NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial

9 hours ago

Press Release

NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering

Jul 24

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 23

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 22